EYES News and Press, Second Sight Medical Products Inc. From 02/03/20

Gainers: OpGen (NASDAQ: OPGN ) +49% . More news on: OpGen, Inc., Insmed Incorporated, Artelo Biosciences, Inc., Stocks on the move, , Read more ...

Second Sight Medical Products, Inc. (EYES) Q3 2019 Earnings Conference Call November 14, 2019 04:30 PM ET Company Participants Lisa Wilson - In-Site Communications, Investor Relations Will McGuire - President and Chief Executive Officer John Blake - Chief Financial Officer Con...

Second Sight (NASDAQ: EYES ): Q3 GAAP EPS of -$0.06 in-line. Revenue of $0.47M (-79.1% Y/Y) misses by $0.47M . Shares +5.9% . Press Release More news on: Second Sight Medical Products, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, ,

-- Reached agreement with FDA regarding the primary efficacy endpoint for the Orion pivotal trial -- Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics ...

Second Sight Medical Products, Inc. (NASDAQ: EYES), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision to blind individuals, will release its financial results for the third quarter of 2019 on Thursday, Nove...

The major point for this article is to discuss the conflicting information that MannKind has issued in recent public events, information that is in direct conflict with information shared on every Afrezza prescription that is filled for a patient. The nature of this conflict is critical inform...

Initiative a Joint Collaboration with the John Hopkins University Applied Physics Laboratory Second Sight Medical Products, Inc. (NASDAQ: EYES) ("Second Sight" or the “Company"), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create...

The following slide deck was published by Second Sight Medical Products, Inc. in conjunction with this Read more ...

Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics today announced that Will McGuire, President and Chief Executive Officer, and John Blake, Chief Financial O...

Second Sight Medical Products, Inc. (NASDAQ:EYES) Q2 2019 Earnings Conference Call August 6, 2019 4:30 PM ET Company Participants Lisa Wilson - Investor Relations Will McGuire - Chief Executive Officer John Blake - Chief Financial Officer Conference Call Participants Am...